Oz Azam beefs up Tmu­ni­ty's to­tal raise to $231M as they steer to­ward hu­man da­ta in the dri­ve to cell ther­a­py 2.0

The CEO of Tmu­ni­ty be­lieves that if you want to build a dif­fer­ent kind of cell ther­a­py com­pa­ny, you need a dif­fer­ent kind of in­vestor syn­di­cate to back your play.

So Us­man “Oz” Azam is par­tic­u­lar­ly jazzed that the Sil­i­con Val­ley gu­rus at An­dreessen Horowitz elect­ed to lead the lat­est round at the Philadel­phia-based biotech, adding $75 mil­lion to­day to a to­tal raise that now tal­lies up to $231 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.